BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1055@pharmaconomics
DTSTAMP:20260707T051033Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:LRMR Phase 2 — nomlabofusp (estimated date)
DESCRIPTION:Phase 2 trial results for nomlabofusp in Friedreich's ataxia are due ~ Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1374690/000119312526115119/lrmr-ex99_1.htm\n\nTrack it: https://www.pharmaconomics.com/e/1055
URL:https://www.pharmaconomics.com/e/1055
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:LRMR catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR